Autoantibody Formation and Mapping of Immunogenic Epitopes against Cold-Shock-Protein YB-1 in Cancer Patients and Healthy Controls.

antigenicity autoantibody cold shock proteins peptide array protein cleavage

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
25 Nov 2020
Historique:
received: 30 08 2020
revised: 16 11 2020
accepted: 18 11 2020
entrez: 1 12 2020
pubmed: 2 12 2020
medline: 2 12 2020
Statut: epublish

Résumé

Cold shock Y-box binding protein-1 participates in cancer cell transformation and mediates invasive cell growth. It is unknown whether an autoimmune response against cancerous human YB-1 with posttranslational protein modifications or processing develops. We performed a systematic analysis for autoantibody formation directed against conformational and linear epitopes within the protein. Full-length and truncated recombinant proteins from prokaryotic and eukaryotic cells were generated. Characterization revealed a pattern of spontaneous protein cleavage, predominantly with the prokaryotic protein. Autoantibodies against prokaryotic, but not eukaryotic full-length and cleaved human YB-1 protein fragments were detected in both, healthy volunteers and cancer patients. A mapping of immunogenic epitopes performed with truncated

Identifiants

pubmed: 33255653
pii: cancers12123507
doi: 10.3390/cancers12123507
pmc: PMC7759818
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)
ID : 97850925 - SFB854 A01, GRK2408, project 8 to PRM, grants ME-1365/7-2 and ME-1365/9-2

Références

Biochem Biophys Res Commun. 2002 Dec 13;299(4):549-54
pubmed: 12459173
Int J Cancer. 2002 Jan 20;97(3):278-82
pubmed: 11774277
PLoS One. 2013 Apr 02;8(4):e60726
pubmed: 23589757
Oncologist. 2018 Aug;23(8):900-911
pubmed: 29622701
Kidney Int. 2017 Nov;92(5):1157-1177
pubmed: 28610763
J Biol Chem. 2019 Jul 12;294(28):10998-11010
pubmed: 31160337
Cell Signal. 2015 Dec;27(12):2355-62
pubmed: 26343856
J Cancer. 2017 Jul 3;8(10):1900-1907
pubmed: 28819388
Semin Immunol. 2020 Feb;47:101388
pubmed: 31924500
PLoS One. 2018 Mar 19;13(3):e0193960
pubmed: 29554146
Biochim Biophys Acta. 2013 Feb;1834(2):559-67
pubmed: 23220387
EMBO Rep. 2009 Jul;10(7):783-9
pubmed: 19483673
Protein J. 2017 Feb;36(1):1-6
pubmed: 28108801
Proc Natl Acad Sci U S A. 1994 May 24;91(11):5119-23
pubmed: 8197194
Cancer Res. 1999 Jan 15;59(2):342-6
pubmed: 9927044
J Proteomics. 2017 Jan 6;150:297-309
pubmed: 27746255
Biochem J. 2013 Jan 1;449(1):11-23
pubmed: 23216250
Wiley Interdiscip Rev RNA. 2014 Jan-Feb;5(1):95-110
pubmed: 24217978
BMC Cancer. 2011 May 20;11:185
pubmed: 21595987
FEBS J. 2007 Mar;274(5):1265-79
pubmed: 17266726
Nat Commun. 2018 Dec 6;9(1):5224
pubmed: 30523250
BMC Cancer. 2009 Nov 24;9:410
pubmed: 19930682
J Biol Chem. 2005 Mar 4;280(9):7702-11
pubmed: 15615704
Methods Enzymol. 2000;326:245-54
pubmed: 11036646
Autoimmun Rev. 2016 May;15(5):477-83
pubmed: 26827909
EMBO J. 2005 Oct 19;24(20):3602-12
pubmed: 16193061
Biochem Biophys Res Commun. 2010 Jul 30;398(3):482-8
pubmed: 20599698
Biochemistry (Mosc). 2020 Jan;85(Suppl 1):S1-S19
pubmed: 32087051
EMBO J. 2001 Oct 1;20(19):5491-502
pubmed: 11574481
Methods Mol Biol. 2013;1018:107-10
pubmed: 23681621
J Biol Chem. 2009 Sep 25;284(39):26928-40
pubmed: 19640841
Trends Cancer. 2017 Mar;3(3):198-213
pubmed: 28718432
J Cell Biochem. 2013 Dec;114(12):2753-69
pubmed: 23804301
J Biol Chem. 1995 Feb 17;270(7):3186-92
pubmed: 7852402
Cell Cycle. 2013 Dec 15;12(24):3791-803
pubmed: 24107631
Scand J Immunol. 2020 Feb;91(2):e12829
pubmed: 31536647
Gene. 1988 Dec 20;73(2):499-507
pubmed: 2977358
Thorax. 2008 Mar;63(3):228-33
pubmed: 17932110
Transl Psychiatry. 2013 Jul 09;3:e277
pubmed: 23838888
Oncogene. 2005 Jun 16;24(26):4281-92
pubmed: 15806160
Atherosclerosis. 2018 Nov;278:156-165
pubmed: 30278358
Biochemistry. 2004 Aug 10;43(31):10237-46
pubmed: 15287751
Nucleic Acids Res. 2020 Sep 18;48(16):9361-9371
pubmed: 32710623
Oncotarget. 2018 Apr 10;9(27):19039-19049
pubmed: 29721182
J Biomed Sci. 2019 May 27;26(1):42
pubmed: 31133011
Biochimie. 2015 Dec;119:36-44
pubmed: 26453809
BMC Cancer. 2014 Jan 20;14:33
pubmed: 24443788
Hepat Mon. 2013 Jul 03;13(7):e8918
pubmed: 24069038
Methods Mol Biol. 2011;681:259-80
pubmed: 20978970
Arthritis Rheum. 2011 Mar;63(3):597-602
pubmed: 21360488

Auteurs

Ronnie Morgenroth (R)

Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Leipziger Str. 40, 39120 Magdeburg, Germany.

Charlotte Reichardt (C)

Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Leipziger Str. 40, 39120 Magdeburg, Germany.

Johannes Steffen (J)

Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Leipziger Str. 40, 39120 Magdeburg, Germany.

Stefan Busse (S)

Clinic of Psychiatry and Psychotherapy, Otto-von-Guericke University Magdeburg, Leipziger Str. 40, 39120 Magdeburg, Germany.

Ronald Frank (R)

AIMS Scientific Products GmbH, Galenusstr. 60, 13187 Berlin, Germany.

Harald Heidecke (H)

CellTrend GmbH, im Biotechnologiepark 3, 14943 Luckenwalde, Germany.

Peter R Mertens (PR)

Clinic of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University Magdeburg, Leipziger Str. 40, 39120 Magdeburg, Germany.

Classifications MeSH